Diabetes: Immunotherapy
Commons · Question 22318 · Tabled 28 Aug 2026 · Department of Health and Social Care · Official record
Answered 21 Sep 2026
Question
Asked by Juliet Campbell
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential benefits of funding immunotherapy research for people with early-stage type 1 diabetes.
Answer
Answered by James Frith, 21 Sep 2026
The Department delivers research into the diagnosis, treatment, and management of type 1 diabetes through the research infrastructure of the National Institute for Health and Care Research (NIHR), comprised of biomedical research centres (BRCs), clinical ...